By analyzing existing basic indicators between Greenbrook Tms and Community, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Community with a short position in Greenbrook Tms. Check out our
pair correlation module for more information.
Let's begin by analyzing the assets.
One of the ways to look at asset utilization of Greenbrook is to check how much profit was generated for every dollar of assets it reports. Greenbrook Tms retains a negative application of resources of -20.66 (percent), losing $0.21 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Greenbrook Tms shows how discouraging it operates for each dollar spent on its resources.
Out of tens of thousands of stocks, funds, and ETFs that trade on global exchanges each represent an individual company which you can analyze using comparative analysis. To determine which one of the two entities, such as Greenbrook or Augmedix is a better fit for your portfolio, analyzing a few basic fundamental indicators is a good first step.
How important is Greenbrook TMS's Liquidity
Greenbrook TMS
financial leverage refers to using borrowed capital as a funding source to finance Greenbrook TMS ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Greenbrook TMS financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Greenbrook TMS's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Greenbrook TMS's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Greenbrook TMS's total debt and its cash.
Correlation Between Greenbrook and Augmedix
In general, Delisted Stock analysis is a method for investors and traders to make individual buying and selling decisions. Stock correlation analysis is also essential because it can help investors realize that they may not be as diversified as they think. Risk management strategies are usually required to make sure all portfolios are properly aligned against their risk tolerance level. You can consider holding Greenbrook TMS together with similar or unrelated positions with a negative correlation. For example, you can also add Augmedix to your portfolio. If Augmedix is not perfectly correlated to Greenbrook TMS it will diversify some of the market risks out of the positively correlated stocks in your portfolio. However, the disadvantage of this sort of hedging is that it can potentially affect your investment returns throughout market cycles. When Greenbrook TMS, for example, performs excellent and delivers stable returns, the negatively correlated position you locked in as a hedge may drag your returns down.
Are you currently holding both Greenbrook TMS and Augmedix in your portfolio? Please note if you are using this as a pair-trade strategy between Greenbrook TMS and Augmedix, watch out for correlation discrepancy over time. Relying on the historical price correlations and assuming that it will not change may lead to short-term losses. Please check
pair correlation details between GBNH and AUGX for more information.
Breaking it down a bit more
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Revenue Breakdown
Now, let's check Greenbrook Tms revenue. Based on the latest financial disclosure, Greenbrook Tms reported 48.06
M of revenue. This is 99.37% lower than that of the Healthcare sector and significantly higher than that of the
Medical Care Facilities industry. The revenue for all United States stocks is 99.49% higher than that of the firm. As for Community Health we see revenue of 11.78
B, which is much higher than that of the Medical Care Facilities
| GBNH | 48.06 Million | 0.41 |
| Sector | 0.0 | 0.0 |
| CYH | 11.78 Billion | 99.59 |
Over 3 percent rise for Greenbrook Tms. What does it mean for stockholders?
Current market risk adjusted performance is at -1.13. Greenbrook Tms exhibits very low volatility with skewness of -1.53 and kurtosis of 4.84. However, we advise investors to further study Greenbrook Tms technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Greenbrook Tms' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Greenbrook Tms' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Greenbrook Tms Implied Volatility
Greenbrook Tms' implied volatility exposes the market's sentiment of Greenbrook Tms stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Greenbrook Tms' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Greenbrook Tms stock will not fluctuate a lot when Greenbrook Tms' options are near their expiration.
Our Takeaway on Greenbrook Tms Investment
While other entities in the medical care facilities industry are either recovering or due for a correction, Greenbrook Tms may not be performing as strong as the other in terms of long-term growth potentials. All things considered, as of the 7th of January 2022, our research shows that Greenbrook Tms is a rather slightly risky investment opportunity with a
average probability of distress in the next two years. From a slightly different view, the entity currently appears to be
undervalued. Our up-to-date 90 days Buy-Hold-Sell recommendation on the company is
Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Greenbrook TMS. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]
